Published in J Clin Microbiol on June 01, 1980
Microbiology of airway disease in patients with cystic fibrosis. Clin Microbiol Rev (1991) 7.12
Occurrence of hypermutable Pseudomonas aeruginosa in cystic fibrosis patients is associated with the oxidative stress caused by chronic lung inflammation. Antimicrob Agents Chemother (2005) 1.94
Production of elastase, exotoxin A, and alkaline protease in sputa during pulmonary exacerbation of cystic fibrosis in patients chronically infected by Pseudomonas aeruginosa. J Clin Microbiol (1995) 1.40
Reliability of quantitative real-time PCR for bacterial detection in cystic fibrosis airway specimens. PLoS One (2010) 1.37
Simple method for quantifying viable bacterial numbers in sputum. J Clin Pathol (1995) 1.13
Optimum use of selective plated media in primary processing of respiratory tract specimens from patients with cystic fibrosis. J Clin Microbiol (1992) 1.11
High-level beta-lactamase activity in sputum samples from cystic fibrosis patients during antipseudomonal treatment. Antimicrob Agents Chemother (1992) 1.07
Utility of gram stain in evaluation of sputa from patients with cystic fibrosis. J Clin Microbiol (1994) 0.93
Interspecific small molecule interactions between clinical isolates of Pseudomonas aeruginosa and Staphylococcus aureus from adult cystic fibrosis patients. PLoS One (2014) 0.89
Microbiological processing of respiratory specimens from patients with cystic fibrosis. Can J Infect Dis (1993) 0.86
Human serum activities against Hemophilus influenzae, type b. J Clin Invest (1972) 7.85
Antibiotic susceptibility testing of Pseudomonas aeruginosa: selection of a control strain and criteria for magnesium and calcium content in media. J Infect Dis (1974) 7.65
The bacteriology of chronic bronchitis. Lancet (1953) 4.84
The effects of four antimicrobial drug regimens on sputum superinfection in hospitalized patients. Am Rev Respir Dis (1962) 4.19
Liquefaction of sputum for bacteriological examination. Lancet (1953) 3.26
Quantitation of microorganisms in sputum. Appl Microbiol (1969) 2.16
Value of dilute inocula in cultural examination of sputum. Lancet (1965) 1.96
Carbenicillin and gentamicin: pharmacologic studies in patients with cystic fibrosis and pseudomonas pulmonary infections. J Pediatr (1971) 1.75
Diagnostic and therapeutic advantages of serial quantitative cultures of fresh sputum in acute bacterial pneumonia. Am Rev Respir Dis (1969) 1.69
Bacteriology of expectorated sputum with quantitative culture and wash technique compared to transtracheal aspirates. Am Rev Respir Dis (1978) 1.45
N-ACETYL-L-CYSTEINE AS LIQUEFYING AGENT IN THE BACTERIOLOGICAL EXAMINATION OF SPUTUM. Tubercle (1964) 1.40
Effect of N-acetylcysteine on antibiotic activity and bacterial growth in vitro. J Clin Microbiol (1977) 1.31
Quantitative sputum culture as a means of excluding false positive reports in the routine microbiology laboratory. J Clin Pathol (1972) 1.29
Sputum liquefying agents: a comparative in vitro evaluation. J Lab Clin Med (1969) 1.24
Quantitative bacteriology of sputum. Am Rev Respir Dis (1968) 1.14
Use of a pancreatin-trypsin solution for the liquefaction of sputa for routine bacteriological examination. J Clin Pathol (1968) 1.06
Carbenicillin treatment of Pseudomonas pulmonary infection. Use in children with cystic fibrosis. Am J Dis Child (1970) 1.01
Tobramycin in treatment of infections due to Pseudomonas aeruginosa in patients with cystic fibrosis. J Infect Dis (1976) 0.81
Quantitative bacteriological analysis of sputum as a test of antibiotic efficacy. Appl Microbiol (1967) 0.80
Medication errors and adverse drug events in pediatric inpatients. JAMA (2001) 11.34
Effect of aerosolized recombinant human DNase on exacerbations of respiratory symptoms and on pulmonary function in patients with cystic fibrosis. The Pulmozyme Study Group. N Engl J Med (1994) 7.98
Chromatin cleavage in apoptosis: association with condensed chromatin morphology and dependence on macromolecular synthesis. J Pathol (1984) 6.67
A rapid chemical assay for gentamicin. N Engl J Med (1972) 6.36
Intermittent administration of inhaled tobramycin in patients with cystic fibrosis. Cystic Fibrosis Inhaled Tobramycin Study Group. N Engl J Med (1999) 6.23
Haemophilus influenzae meningitis in infant rats after intranasal inoculation. J Infect Dis (1974) 4.94
Longitudinal assessment of Pseudomonas aeruginosa in young children with cystic fibrosis. J Infect Dis (2000) 4.93
Production of Haemophilus influenzae b meningitis in infant rats by intraperitoneal inoculation. Infect Immun (1973) 4.80
Rapid dissemination of beta-lactamase-producing, aminoglycoside-resistant Enterococcus faecalis among patients and staff on an infant-toddler surgical ward. N Engl J Med (1990) 4.40
Characterization of non-beta-lactamase-mediated ampicillin resistance in Haemophilus influenzae. Antimicrob Agents Chemother (1984) 4.25
Photoactivated gamma-secretase inhibitors directed to the active site covalently label presenilin 1. Nature (2000) 4.12
Broadly protective vaccine for Staphylococcus aureus based on an in vivo-expressed antigen. Science (1999) 4.08
2-Aryl tryptamines: selective high-affinity antagonists for the h5-HT2A receptor. Bioorg Med Chem Lett (2000) 4.03
Chronic Lyme borreliosis in the laboratory mouse. Am J Pathol (1993) 3.82
Coagulase-negative staphylococci: role as pathogens. Annu Rev Med (1999) 3.59
Score for Neonatal Acute Physiology: a physiologic severity index for neonatal intensive care. Pediatrics (1993) 3.54
The ica locus of Staphylococcus epidermidis encodes production of the capsular polysaccharide/adhesin. Infect Immun (1998) 3.44
Improved enzymatic assay of chloramphenicol. Clin Chem (1978) 3.31
Cause, prevalence, and response to occupational musculoskeletal injuries reported by physical therapists and physical therapist assistants. Phys Ther (1999) 3.16
Isolation and characterization of a capsular polysaccharide adhesin from Staphylococcus epidermidis. J Infect Dis (1988) 3.15
Use of HEp-2 cells for improved isolation and passage of Chlamydia pneumoniae. J Clin Microbiol (1992) 3.10
The association of Chlamydia pneumoniae infection and reactive airway disease in children. Arch Pediatr Adolesc Med (1994) 2.92
Association of intravenous lipid emulsion and coagulase-negative staphylococcal bacteremia in neonatal intensive care units. N Engl J Med (1990) 2.78
Hemophilus influenzae type B susceptibility to 17 antibiotics. J Pediatr (1975) 2.74
Standardizing Chlamydia pneumoniae assays: recommendations from the Centers for Disease Control and Prevention (USA) and the Laboratory Centre for Disease Control (Canada). Clin Infect Dis (2001) 2.71
Lyme borreliosis in genetically resistant and susceptible mice with severe combined immunodeficiency. Am J Trop Med Hyg (1992) 2.71
Evaluation of blood culture procedures in a pediatric hospital. J Clin Microbiol (1979) 2.59
Gentamicin:adenine mononucleotide transferase: partial purification, characterization, and use in the clinical quantitation of gentamicin. J Infect Dis (1974) 2.45
Mycoplasma pneumoniae and Chlamydia pneumoniae in pediatric community-acquired pneumonia: comparative efficacy and safety of clarithromycin vs. erythromycin ethylsuccinate. Pediatr Infect Dis J (1995) 2.44
Rapid detection of chloramphenicol resistance in Haemophilus influenzae. Antimicrob Agents Chemother (1981) 2.41
Pseudomonas cepacia: biology, mechanisms of virulence, epidemiology. J Pediatr (1986) 2.38
Failure to detect ampicillin-resistant, non-beta-lactamase-producing Haemophilus influenzae by standard disk susceptibility testing. Antimicrob Agents Chemother (1986) 2.38
L-685,458, an aspartyl protease transition state mimic, is a potent inhibitor of amyloid beta-protein precursor gamma-secretase activity. Biochemistry (2000) 2.36
Infection with Chlamydia pneumoniae in Brooklyn. J Infect Dis (1991) 2.35
Immune response after splenectomy. Lancet (1978) 2.31
Is the acetylcholine receptor a rabies virus receptor? Science (1982) 2.30
Relative penicillin G resistance in Neisseria meningitidis and reduced affinity of penicillin-binding protein 3. Antimicrob Agents Chemother (1988) 2.28
Bacterial colonization of neonates admitted to an intensive care environment. J Pediatr (1978) 2.24
In vitro susceptibilities of Chlamydia pneumoniae (Chlamydia sp. strain TWAR). Antimicrob Agents Chemother (1989) 2.13
Failure to detect Chlamydia pneumoniae in the central nervous system of patients with MS. Neurology (2000) 2.12
Failure to detect Chlamydia pneumoniae in coronary atheromas of patients undergoing atherectomy. J Infect Dis (1996) 2.12
Nonspecific proliferative responses of murine lymphocytes to Borrelia burgdorferi antigens. J Infect Dis (1992) 2.11
A randomized trial comparing povidone-iodine to a chlorhexidine gluconate-impregnated dressing for prevention of central venous catheter infections in neonates. Pediatrics (2001) 2.10
Studies of the effectiveness of an isolation ward. J Hyg (Lond) (1969) 2.10
The immunization status of children with spina bifida. Am J Dis Child (1993) 2.07
Characterization of chloramphenicol-resistant Haemophilus influenzae. Antimicrob Agents Chemother (1980) 2.07
Quantitative blood cultures in childhood bacteremia. J Pediatr (1978) 2.05
Studies of the aetiology of neonatal hepatitis and biliary atresia. Arch Dis Child (1977) 2.04
Isolation and assay of rabies serogroup viruses in CER cells. Intervirology (1977) 2.03
The role of encapsulation and host age in the clearance of Haemophilus influenzae bacteremia. J Infect Dis (1977) 2.01
Characterization of Haemophilus influenzae type b fimbriae. Infect Immun (1984) 2.00
Antibiotics and invasive Haemophilus influenzae. N Engl J Med (1976) 2.00
Isolation and characterization of transposon mutants of Staphylococcus epidermidis deficient in capsular polysaccharide/adhesin and slime. Infect Immun (1993) 1.99
Microbiology of the vagina in children: normal and potentially pathogenic organisms. Pediatrics (1978) 1.98
Selective media for the quantitation of bacteria in cystic fibrosis sputum. J Med Microbiol (1984) 1.95
The role of pili and capsule in the pathogenesis of neonatal infection with Escherichia coli K1. J Infect Dis (1983) 1.95
Birth weight and illness severity: independent predictors of neonatal mortality. Pediatrics (1993) 1.94
False resistance to imipenem with a microdilution susceptibility testing system. J Clin Microbiol (1991) 1.94
The paradox of Hemophilus infuenzae type B bacteremia in the presence of serum bactericidal activity. J Clin Invest (1976) 1.94
Sepsis and congenital asplenia. J Pediatr (1977) 1.93
T-cell alpha beta + and gamma delta + deficient mice display abnormal but distinct phenotypes toward a natural, widespread infection of the intestinal epithelium. Proc Natl Acad Sci U S A (1996) 1.92
In vitro antibacterial activity of fluorinated analogs of chloramphenicol and thiamphenicol. Antimicrob Agents Chemother (1981) 1.87
Prevalence of asymptomatic nasopharyngeal carriage of Chlamydia pneumoniae in subjectively healthy adults: assessment by polymerase chain reaction-enzyme immunoassay and culture. Clin Infect Dis (1995) 1.86
Aminoglycoside penetration, inactivation, and efficacy in cystic fibrosis sputum. Am Rev Respir Dis (1985) 1.85
Predictive value of oropharyngeal cultures for identifying lower airway bacteria in cystic fibrosis patients. Am Rev Respir Dis (1991) 1.84
Real time patient safety audits: improving safety every day. Qual Saf Health Care (2005) 1.84
Clinical staging in Reye syndrome. Am J Dis Child (1974) 1.84
A permeability barrier as a mechanism of chloramphenicol resistance in Haemophilus influenzae. Antimicrob Agents Chemother (1985) 1.84
Isolation of field rabies virus strains in CER and murine neuroblastoma cell cultures. Intervirology (1978) 1.81
Effect of chronic intermittent administration of inhaled tobramycin on respiratory microbial flora in patients with cystic fibrosis. J Infect Dis (1999) 1.79
Lipid peroxidation by human blood phagocytes. J Clin Invest (1974) 1.79
Riboflavin and mouse hepatic cell structure and function. II. Division of mitochondria during recovery from simple deficiency. J Cell Biol (1969) 1.74
A virulent nonencapsulated Haemophilus influenzae. J Infect Dis (1996) 1.73
A first-generation whole genome-radiation hybrid map spanning the mouse genome. Genome Res (1997) 1.73
Epidemiology of sexually transmitted diseases in rape victims. Rev Infect Dis (1989) 1.73
Use of fluoroquinolones in pediatrics: consensus report of an International Society of Chemotherapy commission. Pediatr Infect Dis J (1995) 1.70
Declining severity adjusted mortality: evidence of improving neonatal intensive care. Pediatrics (1998) 1.70
Neonatal therapeutic intervention scoring system: a therapy-based severity-of-illness index. Pediatrics (1992) 1.67
Detection of relatively penicillin G-resistant Neisseria meningitidis by disk susceptibility testing. Antimicrob Agents Chemother (1987) 1.67
Comparative virulence of Haemophilus influenzae with a type b or type d capsule. Infect Immun (1981) 1.66
Role of immunity in the clearance of bacteremia due to Haemophilus influenzae. J Infect Dis (1978) 1.65
Increasing incidence of ampicillin resistance in Hemophilus influenzae. J Pediatr (1978) 1.63
Lack of specificity of Chlamydiazyme for detection of vaginal chlamydial infection in prepubertal girls. Pediatr Infect Dis J (1989) 1.61
Microbiologic efficacy of azithromycin and susceptibilities to azithromycin of isolates of Chlamydia pneumoniae from adults and children with community-acquired pneumonia. Antimicrob Agents Chemother (1998) 1.60
Effect of inoculum size on the susceptibility of Haemophilus influenzae b to beta-lactam antibiotics. Antimicrob Agents Chemother (1979) 1.60
Cephalothin prophylaxis in cardiac valve surgery. A prospective, double-blind comparison of two-day and six-day regimens. J Thorac Cardiovasc Surg (1977) 1.60
Purification and characterization of Haemophilus influenzae pili, and their structural and serological relatedness to Escherichia coli P and mannose-sensitive pili. J Exp Med (1985) 1.60
Urogenital, maternal and neonatal isolates of Haemophilus influenzae: identification of unusually virulent serologically non-typable clone families and evidence for a new Haemophilus species. J Gen Microbiol (1990) 1.59
Disposition of drugs in cystic fibrosis. III. Acetaminophen. Clin Pharmacol Ther (1991) 1.59
Nosocomial infections in a neonatal intensive care unit. J Infect Dis (1981) 1.58
Occurrence of nosocomial bloodstream infections in six neonatal intensive care units. Pediatr Infect Dis J (2000) 1.58
Prospective study of maternal and infantile infection with Chlamydia trachomatis. Pediatrics (1979) 1.58
Isolation and chemical characterization of a capsular polysaccharide antigen shared by clinical isolates of Enterococcus faecalis and vancomycin-resistant Enterococcus faecium. Infect Immun (1999) 1.57
HL7 document patient record architecture: an XML document architecture based on a shared information model. Proc AMIA Symp (1999) 1.55
In vitro activities of OPC-17116, a new quinolone; ofloxacin; and sparfloxacin against Chlamydia pneumoniae. Antimicrob Agents Chemother (1994) 1.55
Pigment gallstones form as a composite of bacterial microcolonies and pigment solids. Ann Surg (1987) 1.55
Host cell receptors for two strains of Sindbis virus. Arch Virol (1980) 1.51
Control of multiply resistant cocci: do international comparisons help? Lancet Infect Dis (2001) 1.49